Oncopharmpod

Relatlimab + Nivo And the VISION trial

Informações:

Synopsis

Catching on recent FDA approvals on relatlimab/nivolumab (it's relatLimab not relatimab) as well as Lu-PSMA-177 based on the VISION trial.